Weekly Assessment of COVID-19 Epidemiology (WAVE) Prediction
Rapid and efficient development of vaccines for SARS-COV-2 and treatments for COVID-19 requires locating sites with sufficient caseloads, at the right time. The COVID-19 pandemic has also challenged unrelated trials, which are experiencing attrition, incomplete data, and difficulties maintaining sites and recruiting patients.
The WAVE simulator models the trajectory of COVID-19 to provide an evidence-based approach to identify sites:
- Where the population is predicted to experience sufficient incidence of COVID-19 at the optimal time of recruitment and intervention for COVID-19 treatment and vaccine studies
- Where the predicted incidence of COVID-19 is low over the trial period to support studies for non COVID-19 interventions